Antigen presentation by MHC-E: a putative target for vaccination?

Area of Science:

• Immunology
• Molecular Biology
• Vaccinology

Background:

• Human Leukocyte Antigen-E (HLA-E) is a conserved molecule important for immune regulation.
• Understanding HLA-E's antigen presentation pathways is key for vaccine development, especially for targeting diverse populations.
• Current knowledge on HLA-E peptide processing and presentation, particularly non-canonical peptides, is incomplete.

Purpose of the Study:

• To investigate alternative, transporter associated with antigen presentation (TAP)-independent pathways for HLA-E antigen presentation.
• To explore the role of these pathways in infections like cytomegalovirus (CMV) and Mycobacterium tuberculosis.
• To inform the design of novel HLA-E targeting vaccines.

Main Methods:

• Analysis of HLA-E peptide-binding motifs.
• Investigation of antigen processing and presentation mechanisms.
• Comparative studies in viral (CMV) and bacterial (M. tuberculosis) infection models.

Main Results:

• Refined predictive motifs facilitate HLA-E peptide discovery.
• HLA-E accommodates diverse self and microbial peptides.
• Evidence suggests TAP-independent pathways are essential for HLA-E presentation of non-canonical peptides, including during CMV infection.

Conclusions:

• Three novel TAP-independent pathways for HLA-E antigen presentation are proposed.
• These pathways are relevant for infections caused by CMV and M. tuberculosis.
• Findings provide a basis for designing HLA-E-based vaccines effective across diverse genetic backgrounds and against various pathogens and cancers.